Real-life long-term omalizumab therapy in children with severe allergic asthma.

Antoine Deschildre Christophe Marguet Carole Langlois Isabelle Pin Jean-Luc Rittié Jocelyne Derelle Rola Abou Taam Michael Fayon Jacques Brouard Jean Christophe Dubus Daniel Siret Laurence Weiss Guillaume Pouessel Laurent Beghin Jocelyne Just

Eur Respir J

Centre de l'Asthme et des Allergies, Hôpital d'Enfants Armand-Trousseau, Paris, France INSERM, UMR_S 1136, Sorbonne Universités, UPMC Université Paris 06, Paris, France Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe EPAR, Paris, France.

Published: September 2015

Download full-text PDF	Source
http://dx.doi.org/10.1183/09031936.00008115	DOI Listing

Publication Analysis

Top Keywords

real-life long-term

long-term omalizumab

omalizumab therapy

therapy children

children severe

severe allergic

allergic asthma

real-life

omalizumab

therapy

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!